News and views

People in Scotland with chronic lymphocytic leukaemia set to benefit from a new drug

Doctor consulting with patient

Some people with untreated chronic lymphocytic leukaemia (CLL) in Scotland will now be able to have access to obinutuzumab (Gazyvaro®) if their doctor feels it is the right treatment for them, after the Scottish Medicines Consortium (SMC) gave it the go ahead for routine use on the NHS this week.